title: An autoregulatory loop between Nrf2 and Cul3-Rbx1 controls their cellular abundance.
abstract: The INrf2 (Keap1)/Cul3-Rbx1 complex constantly degrades Nrf2 under normal conditions. When a cell encounters oxidative or electrophilic stress, Nrf2 dissociates from the INrf2/Cul3-Rbx1 complex and translocates into the nucleus. In the nucleus, Nrf2 activates a myriad of antioxidant and defensive genes that protect cells. Nrf2 is then exported out of the nucleus and degraded. INrf2 serves as a substrate adaptor to link Nrf2 to Cul3 and Rbx1. Cul3 and Rbx1 make up the ubiquitin ligase complex that is responsible for the ubiquitination and degradation of Nrf2. Previously we have shown a feedback autoregulatory loop between Nrf2 and INrf2 indicating that Nrf2 regulates INrf2 by controlling its transcription. Here we are extending this research by demonstrating the presence of another feedback autoregulatory loop between Cul3-Rbx1 and Nrf2. Experiments using Hepa-1 and HepG2 cells indicate that Nrf2 controls its own degradation by regulating expression and induction of Cul3-Rbx1 genes. Treatment with the antioxidant tert-Butylhydroquinone (t-BHQ) leads to induction of Cul3-Rbx1 genes. Mutagenesis and transfection experiments identified an antioxidant response element in the forward and reverse strands of the proximal Cul3 and Rbx1 promoters, respectively, that Nrf2 binds and regulates expression and antioxidant induction of the Cul3-Rbx1 genes. In addition, short interfering RNA inhibition and overexpression of Nrf2 led to a respective decrease and increase in Cul3-Rbx1 gene expression. The increase in Cul3-Rbx1 leads to ubiquitination and degradation of Nrf2. These data suggest that Nrf2 regulates Cul3-Rbx1 by controlling regulation of expression and induction of Cul3-Rbx1. The induction of Cul3-Rbx1 control Nrf2 by increasing degradation.
authors.affiliation: Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
authors.forename: James W
authors.initials: JW
authors.lastname: Kaspar
authors.forename: Anil K
authors.initials: AK
authors.lastname: Jaiswal
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism*; D045744:Cell Line, Tumor; D044842:Cullin Proteins / Q000378:metabolism*; D005786:Gene Expression Regulation; D006801:Humans; D051379:Mice; D008954:Models, Biological; D051267:NF-E2-Related Factor 2 / Q000378:metabolism*; D014158:Transcription, Genetic; D025801:Ubiquitin / Q000378:metabolism
chemical_list: D000975:Antioxidants; C503645:CUL3 protein, human; D002352:Carrier Proteins; C503646:Cul3 protein, mouse; D044842:Cullin Proteins; D051267:NF-E2-Related Factor 2; C495635:NFE2L2 protein, human; C495636:Nfe2l2 protein, mouse; C479529:RBX1 protein, human; C540494:RBX1 protein, mouse; D025801:Ubiquitin
references.citation: J Biol Chem. 2007 Jun 1;282(22):16502-10
references.pmid: 17403689
references.citation: J Biol Chem. 2009 May 15;284(20):13856-13868
references.pmid: 19279002
references.citation: J Biol Chem. 2003 Nov 7;278(45):44675-82
references.pmid: 12947090
references.citation: Oncogene. 2001 Jun 28;20(29):3906-17
references.pmid: 11439354
references.citation: Hepatology. 2007 Nov;46(5):1597-610
references.pmid: 17668877
references.citation: Free Radic Biol Med. 1995 Jun;18(6):1033-77
references.pmid: 7628729
references.citation: Genes Cells. 2003 Apr;8(4):379-91
references.pmid: 12653965
references.citation: Mol Cell Biol. 2005 Jan;25(1):162-71
references.pmid: 15601839
references.citation: Genes Dev. 1999 Jan 1;13(1):76-86
references.pmid: 9887101
references.citation: Mol Cell Biol. 2005 Jun;25(12):4914-23
references.pmid: 15923610
references.citation: Free Radic Biol Med. 2004 May 15;36(10):1199-207
references.pmid: 15110384
references.citation: Annu Rev Microbiol. 1999;53:495-523
references.pmid: 10547699
references.citation: Mech Dev. 1991 Mar;34(1):3-9
references.pmid: 1911393
references.citation: Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3410-5
references.pmid: 11248092
references.citation: J Biol Chem. 2005 Aug 12;280(32):29158-68
references.pmid: 15901726
references.citation: Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2046-51
references.pmid: 14764898
references.citation: Physiol Rev. 1993 Oct;73(4):797-821
references.pmid: 8415926
references.citation: Mol Cell Biol. 2004 Dec;24(24):10941-53
references.pmid: 15572695
references.citation: J Biol Chem. 2003 Jan 24;278(4):2396-402
references.pmid: 12441344
references.citation: Nat Genet. 2003 Nov;35(3):238-45
references.pmid: 14517554
references.citation: Biochem J. 2004 Jun 1;380(Pt 2):515-21
references.pmid: 14960151
references.citation: J Biol Chem. 2006 Apr 28;281(17):12132-42
references.pmid: 16513647
references.citation: Drug Metab Rev. 2006;38(4):769-89
references.pmid: 17145701
references.citation: Curr Top Cell Regul. 2000;36:201-16
references.pmid: 10842753
references.citation: Oncogene. 2002 Oct 3;21(44):6829-34
references.pmid: 12360409
references.citation: Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14960-5
references.pmid: 8962164
references.citation: Free Radic Biol Med. 2006 Apr 1;40(7):1119-30
references.pmid: 16545679
references.citation: J Biol Chem. 1990 Aug 25;265(24):14648-53
references.pmid: 2387873
references.citation: J Clin Oncol. 2005 Jul 20;23(21):4776-89
references.pmid: 16034054
references.citation: Adv Enzyme Regul. 2006;46:113-40
references.pmid: 16887173
references.citation: Toxicology. 2008 Apr 3;246(1):24-33
references.pmid: 18083283
references.citation: J Biol Chem. 2003 Feb 14;278(7):4536-41
references.pmid: 12446695
references.citation: Mol Cell. 2003 Sep;12(3):783-90
references.pmid: 14527422
references.citation: Cancer Res. 2007 Jan 15;67(2):546-54
references.pmid: 17234762